Publications by authors named "Claude Monj"
Article Synopsis
- In 2020, the Covid-19 pandemic disrupted routine immunization efforts, affecting the Global Polio Eradication Initiative's work on vaccine-derived poliovirus outbreaks in sub-Saharan Africa.
- A qualitative study involving focus groups and interviews in Cameroon and Ethiopia revealed that the pandemic led to decreased caregiver confidence in routine vaccinations and eroded trust between caregivers and frontline workers.
- To improve community support for future oral polio vaccine (OPV) campaigns, stakeholders suggested rebuilding trust, ensuring consistent communication, boosting resources for frontline workers, and utilizing local influencers.
Background: The Global Polio Eradication Initiative introduced novel oral polio vaccine Type 2 (nOPV2) to address circulating vaccine-derived poliovirus Type 2 (cVDPV2). Although nOPV2 is a more genetically stable vaccine, it may not have the immediate trust of communities and health workers due to its novelty, potential side effects, and introduction under an Emergency Use Listing (EUL). We explored how nOPV2 introduction might be perceived by stakeholders and identified communications barriers related to nOPV2 hesitancy.
View Article and Find Full Text PDF